3SBio will grant Pfizer exclusive global rights, not including China, to develop, manufacture and commercialize SSGJ-707, a ...

Pfizer global commercial access partnerships director. Addressing challenges in prevention, personnel, facilities, and treatment can have a sweeping effect on the health of a population.

(NASDAQ:GH) on Thursday announced a strategic collaboration with Pfizer ... for its global clinical trials, which include China cohorts. In July 2022, Guardant announced a strategic partnership ...

we are committed to accelerating the availability of global innovations while fostering partnerships with governments, healthcare providers, and key stakeholders,” Serhat Yalcinkaya, Pfizer Gulf ...

BBC works with Pfizer Global Research & Development ... biotech and venture capital partners. Two BBC units are located in the San Francisco Bay area and San Diego; a third, dedicated to RNA ...

Pfizer's reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics ... If those results are positive the partners have said they could file for approval in the ...

Pfizer (NYSE:PFE) is overhauling its cardiometabolic ... antagonist and pursuing external opportunities that could include partnerships or acquisitions. That strategic pivot comes as shares ...

Pharmaceutical and biotechnology company Pfizer marks 70 years of dedication to its mission of advancing patient health in ...

With the company’s Q1 2025 results on Tuesday, Pfizer (NYSE:PFE) indicated plans to explore acquisitions or partnerships to add cardiometabolic assets, including weight loss therapies ...

Meanwhile, a new partnership could address global inequities in vaccine access ... For its international phase 3 trial, Pfizer recruited nearly 44,000 subjects on five continents to represent ...